Fosun International’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Fosun International’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-35,038	Closed	-$1.16M	–	297
2019 Q2	$1.16M	Buy	35,038 +10,635	+44%	+$577K	0.08%	149
2019 Q1	$1.37M	Buy	24,403 +2,900	+13%	+$157K	0.09%	131
2018 Q4	$935K	Buy	+21,503	New	+$1.18M	0.06%	138

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fosun International's VBIV Position: Q3 2019 in Review

Fosun International sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2019, closing a stake of 35,038 shares — an estimated $1.16M sold.

Fosun International first reported a position in VBIV in Q4 2018 and held it in 3 quarters. The position peaked at $1.37M in Q1 2019. 70 funds tracked by Wall St. Rank hold VBIV as of Q3 2019.

Fosun International reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2019 after selling out during the quarter.
Fosun International sold 35,038 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2019, an estimated $1.16M.
Fosun International first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2018 and held it in 3 quarters.
Fosun International's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.37M in Q1 2019.
70 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.